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A simple, sensitive, rapid and economic chromatographic method has been developed for determination of 
metoprolol tartarate and hydrochlorothiazide in human plasma using paracetamol as an internal standard. 
The analytical technique used for method development was high-performance thin-layer chromatography. 
HPTLC Camag with precoated silica gel Plate 60F254 (20 cm×10 cm) at 250 µm thicknesses (E. Merck, 
Darmstadt, Germany) was used as the stationary phase. The mobile phase used consisted of chloroform: 
methanol: ammonia (9:1:0.5v/v/v). Densitometric analysis was carried out at a wavelength of 239 nm. 
The rf values for hydrochlorothiazide, paracetamol and metoprolol tartarate were 0.13±0.04, 0.28±0.05, 
0.48±0.04, respectively. Plasma samples were extracted by protein precipitation with methanol. 
Concentration ranges of 200, 400, 600, 800, 1000, 1200 ng/mL and 2000, 4000, 6000, 8000, 10000, 
12000 ng/mL of hydrochlorothiazide and metoprolol tartarate, respectively, were used with plasma for the 
calibration curves. The percent recovery of metoprolol tartarate and hydrochlorothiazide was found to be 
77.30 and 77.02 %, respectively. The stability of metoprolol tartarate and hydrochlorothiazide in plasma 
were confirmed during three freeze-thaw cycles (-20 °C) on a bench for 24 hours and post-preparatively 
for 48 hours. The proposed method was validated statistically and proved suitable for determination of 
metoprolol tartarate and hydrochlorothiazide in human plasma.
Uniterms: High performance thin layer chromatography/quantitative analysis. Metoprolol tartarate/
determination in plasma. Hydrochlorothiazide/determination in plasma. Human plasma/quantitative 
analysis. Protein precipitation.
Um método simples, sensível, rápido e econômico empregando a cromatografia em camada delgada de 
alta eficiência (HPTLC) foi desenvolvido para determinação do tartarato de metoprolol e hidroclorotiazida 
em plasma humano, usando paracetamol como padrão interno. Placas prontas de sílica-gel 60F254 
(20 cm×10 cm), 250 µm de espessura, para HPTLC Camag (E. A Merck, Darmstadt, Alemanha) 
foramutilizadas como fase estacionária. A fase móvel utilizada consistiu de clorofórmio: metanol: amônia 
(9:1:0,5 v/v/v). A análise densitométrica foi realizada no comprimento de onda 239 nm. Os valores de 
Rf de hidroclorotiazida, paracetamol e tartarato de metoprolol foram 0.13±0.04, 0.28±0.05, 0.48±0.04 
respectivamente. As proteínas do plasma foram extraídas por precipitação com metanol. Para construção 
das curvas de calibração, empregaram-se intervalos de concentração de 200, 400, 600, 800, 1000,  
1200 ng/mL e 2000, 4000, 6000, 8000, 10000, 12000 ng/mL de hidroclorotiazida e tartarato de metoprolol, 
respectivamente. Os percentuais de recuperação do tartarato de metoprolol e de hidroclorotiazida foram 
de 77,30 e 77,02, respectivamente. A estabilidade do tartarato de metoprolol e de hidroclorotiazida no 
plasma foi confirmada durante três ciclos de congelamento e descongelamento (-20 oC), durante 24 horas 
e póspreparação durante 48 horas. O método proposto foi validado estatisticamente, sendo adequado 
para determinação do tartarato de metoprolol e hidroclorotiazida em plasma humano.
Unitermos: Cromatografia em camada delgada de alta eficiência/análise quantitativa. Tartarato de 
metoprolol/determinação em plasma. Hidroclorotiazida/determinação em plasma. Plasma humano/
análise quantitativa. Precipitação de proteínas.
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INTRODUCTION
Chemically, hydrochlorothiazide (Figure 1) is 
6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-
sulphonamide-1,1-dioxide and metoprolol tartarate is 
1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)
propane-2-ol. Hydrochlorothiazide (HCTZ) is one of 
the oldest thiazide diuretics used to treat hypertension. 
It is often prescribed in combination with other 
antihypertensive drugs such as β-blockers, angiotensin 
converting enzyme inhibitors, or angiotensin II receptor 
blockers (Wellington, 2002). A combination dosage form 
of HCT with the β1-selective (cardio selective) –β-blocker 
Metoprolol tartarate (MET) (Smilide, 1983), is more 
effective than either drug alone in the management of 
hypertension and is effective in patients unresponsive to 
immunotherapy with either agent (Papademetriou et al., 
2006; Hainer, 2007). For the determination of MET in 
human plasma, several methods based on high performance 
liquid chromatography (HPLC) with UV (Aqil et al., 
2007) and fluorescence (Zhaing, 2006) detection, gas 
chromatography-mass spectrometry (Yilmaz, 2009) and 
LC–MS/MS (Gowda et al., 2007; Gao et al., 2010) have 
been reported. Similarly, a method for the determination 
of HCT in human plasma has been developed based on 
HPLC with UV or diode array detection (Zendelovska, 
2004; Erk, 2003) and LC–MS/MS (Ramakrishna et al., 
2005; Liu et al., 2007). No HPTLC method has been 
developed for determination of metoprolol tartarate 
and hydrochlorothiazide in human plasma by protein 
precipitation. Therefore, we developed a new simple, 
sensitive, rapid and economic high-performance thin-layer 
chromatographic method for determination of metoprolol 
tartarate and hydrochlorothiazide in human plasma by 
protein precipitation using paracetamol as an internal 
standard.
We preferred HPTLC over HPLC because the 
former method is useful for simultaneous processing of 
sample and standard, allowing better analytical precision 
and accuracy, several analysts to work simultaneously, 
and shorter analysis time as well as offering lower cost 
per analysis, low maintenance cost, simple sample 
preparation, handling of samples of divergent nature, 
no prior treatment for solvents such as filtration and 
degassing, low mobile phase consumption per sample, no 
interference from previous analysis, fresh stationary and 
mobile phases for each analysis, no contamination, visual 
detection, an open system, on UV-absorbing compounds 
detected by post-chromatographic derivatization.
MATERIAL AND METHODS
Instrumentation
HPTLC Camag with precoated silica gel Plate 
60F254 (20 cm×10 cm) at 250 µm thicknesses (E. Merck, 
Darmstadt, Germany) was used as the stationary phase. 
Sample application was done by using a Camag 100 µL 
syringe and Camag Linomat V applicator. The sample was 
sprayed in the form of narrow bands of 8 mm length at a 
constant rate of 2 µL/s. Linear ascending development was 
carried out in a 20cm×10cm twin trough glass chamber 
(Camag, Muttenz, Switzerland). The densitometric 
scanning was performed by using Camag TLC scanner III 
FIGURA 1 - Structure of metoprolol tartarate (I), hydrochlorothiazide (II) and paracetamol (IS) (III).
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for chamber saturation was optimized to 30 min. The 
length of chromatographic development was 70 mm. The 
densitometric scanning was performed at 239 nm.
Method validation
The method was validated for sensitivity, selectivity, 
precision, accuracy, linearity, recovery and stability. The 
validation of the method was based on FDA guidelines 
and on standard Bioanalytical method validation 
recommendations. The selectivity of the method was 
investigated by analyzing six blank plasma samples. Each 
blank sample was tested for interference using the proposed 
extraction procedure. Five replicates of three QC samples 
(low, mid and high) were used for the determination of 
precision and accuracy. Intra-day and inter-day precision 
were carried out. Precision and accuracies showed 
15% relative standard deviation (RSD) from nominal 
values and at LLOQ these were both 20%. The recovery 
of metoprolol tartarate and hydrochlorothiazide was 
calculated by comparing the peak areas of low, mid, and 
high quality control sample (400, 800, 1200 ng/mL and 
4000, 8000. 12000 ng/mL, respectively) prepared in 
plasma (extracted) with unextracted metoprolol tartarate 
and hydrochlorothiazide, respectively.
S t a b i l i t y  e x p e r i m e n t s  w e r e  u n d e r t a k e n 
to detect degradation of Metoprolol tartarate and 
hydrochlorothiazide under specific conditions. Freeze–
thaw stability was determined at two QC concentrations 
(low, high) after freezing (−20 ◦C) and thawing for three 
cycles and compared with the nominal value. Bench-top 
stability was assessed for low and high QC samples by 
comparing with the nominal value which was stored at 
room temperature for 12 h. The effect of storage within 
the auto-sampler was assessed by comparing QC samples 
injected immediately after preparation with those left in 
the auto-sampler for 48 h.
RESULT AND DISCUSSION
Extraction procedure optimization
One of the most difficult parts during the method 
development was to achieve high and reproducible 
recovery from the solvent used for extraction of the 
drug. Different solvents were tried for the extraction of 
metoprolol tartarate and hydrochlorothiazide from human 
plasma. First, 3 mL each of chloroform and toluene were 
tried for the precipitation of plasma but the recovery 
proved very low. It yielded 55-75% recovery because 
of less precipitation of protein from plasma. Finally, 
supported by win CATS software (V 1.4.2.8121 Camag). 
Evaluation of the chromatogram was done by using peak 
areas.
Chemicals
Metoprolol tartarate (Ajanta Pharmaceuticals, 
Mumbai, Maharashtra, India), hydrochlorothiazide 
(Elder pharmaceuticals, Mumbai, Maharashtra, India) 
and paracetamol (Kirti Pharmachem Ltd., Sinner, 
Maharashtra, India) had 99.80%, 98.70% and 100.1% 
purity, respectively. These were used as received without 
checking their purity. The HPLC grade methanol and 
Analytical Reagent grade Chloroform were purchased 
from s d Fine Chem. Ltd., Mumbai, India. The human 
plasma used for the research work was supplied by Arpan 
Blood Bank, Nashik, Maharashtra, India.
Preparation of stock solution and working 
standard solution
Stock solutions of 1.0 mg/mL each of metoprolol 
tartarate, hydrochlorothiazide and paracetamol were 
prepared in methanol.
Preparation of plasma sample
For HPTLC, in a 15mL centrifuge tube, 2, 4, 6, 8, 10, 
12 µL of working stock solution of hydrochlorothiazide 
was added to drug-free plasma to provide calibration 
standards of 200, 400, 600, 800, 1000, 1200 ng/mL while 
20,40,60,80,100,120 µL of working stock solution of 
metoprolol tartarate was added to drug-free plasma to 
provide calibration standards of 2000, 4000, 6000, 8000, 
10000, 12000 ng/mL and 1000 ng/mL of paracetamol 
(internal standard) and kept constant. The quality control 
(QC) samples were prepared in plasma in the concentration 
range of 400, 800, and 1200 ng/mL and 4000, 8000, and 
12000 ng/mL. Protein precipitation and extraction was 
carried out by using methanol 3 mL and acetonitrile 
0.1 mL by vigorous vortex mixing using a Remi mixer 
for 1 min and centrifuging at 5,000 rpm for 10 min. The 
organic phase was recovered and evaporated to dryness 
on a hot plate. The residual mass was reconstituted with 
1 mL methanol. The analysis was carried using HPTLC.
Chromatographic conditions
Mobile phase was selected as a mixture of 
chloroform, methanol and ammonia in the ratio of 
(9.0:1.0:0.5, v/v/v) for the development of plates. Time 
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methanol was tried and 70–80% recovery obtained. It was 
found that the addition of acetonitrile (0.1 mL) increased 
the precipitation of protein and also the recovery which 
was reproducible and high as compared to other solvents. 
Thus, methanol and acetonitrile (3.0 mL: 0.1 mL) was kept 
as the final solvent for extraction of hydrochlorothiazide 
and metoprolol tartarate. Recovery was done in plain 
extracting solvent from human plasma.
Optimization of chromatographic conditions
Initially, plain solvents such as methanol, ethyl 
acetate, chloroform, toluene, acetone were tried. The spots 
were developed with chloroform and methanol but no 
proper resolution observed among hydrochlorothiazide, 
metoprolol tartarate and paracetamol, also showing the 
tailing. Subsequently, chloroform and methanol at the 
ratio of (8:2, v/v) was tried but again no proper resolution 
was obtained. The proportion of chloroform was then 
increased and of methanol decreased by 1mL, showing 
good resolution. Lastly, the addition of Ammonia solution 
at 0.5 mL helped to reduce the tailing effect and good 
resolution with symmetrical peaks of hydrochlorothiazide, 
paracetamol and metoprolol tartarate were obtained. 
Finally, the mobile phase used consisted of chloroform: 
methanol: Ammonia (9:1: 0.5, v/v/v) which allowed 
good resolution of peaks for hydrochlorothiazide, 
metoprolol tartarate and paracetamol. The Rf values 
for hydrochlorothiazide, paracetamol and metoprolol 
tartarate were found to be 0.13±0.04, 0.28±0.05 and 
0.48±0.04, respectively. Well-defined spots were obtained 
by prewashing the plate using methanol followed by 
activating at 120 ºC for 20 min. The chamber was saturated 
with mobile phase for 25 min at room temperature, 
yielding reproducible Rf values for hydrochlorothiazide, 




A six-point calibration curve was constructed by 
plotting the peak response ratio of hydrochlorothiazide to 
paracetamol versus concentration of hydrochlorothiazide 
and metoprolol tartarate to paracetamol versus 
concentration of metoprolol tartarate in plasma. 
Correlation coefficients were 0.9979 and 0.9954 for 
hydrochlorothiazide and metoprolol tartarate, respectively. 
Linearities were found over the range 2-12 µL/mL and 
20-120 µL/mL for hydrochlorothiazide and metoprolol 
tartarate, respectively. The lower limit of quantification 
was defined as the lowest concentration in the calibration 
curve. The hydrochlorothiazide and metoprolol tartarate 
can be determined at LLOQ 2 µL/mL and 20 µL/mL.
Recovery
Absolute recovery was calculated by comparing 
peak areas obtained from freshly prepared sample 
extracted with unextracted standard solutions of the same 
concentration. Recovery data was determined in triplicates 
at three concentrations (low, mid, high) as recommended 
by the FDA guidelines (US Department, 2001). The 
FIGURE 2 - Densitogram of hydrochlorothiazide (Rf(0.13±0.04), paracetamol Rf(0.28±0.05) and metoprolol tartarate Rf(0.48±0.04).
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TABLE I - Result of recovery of hydrochlorothiazide and 
metoprolol tartarate in human plasma
Sr. No.
Concentration Recovery %RSD
HCTZ MET HCTZ MET HCTZ MET
1 400 4000 77.33 70.59 7.92 11.2
2 800 8000 74.65 84.91 7.32 4.5
3 1200 12000 79.94 75.57 4.9 3.8
TABLE II - Results of precision of hydrochlorothiazide and metoprolol tartarate in human plasma
Precision
Concentration (ng/mL) %RSD %RE
HCTZ MET HCTZ MET HCTZ MET
INTRA
400 4000 2.09 1.20 6.37 4.55
800 8000 0.55 0.92 14.69 10.01
1200 12000 1.57 1.24 7.10 9.76
INTER
400 4000 4.80 2.43 6.88 11.44
800 8000 2.44 7.14 15.82 12.53
1200 12000 1.12 0.73 6.69 8.43
recoveries of hydrochlorothiazide and metoprolol tartarate 
for HPTLC recovery at the three concentrations 400, 800, 
1200 ng/mL and 4000, 8000, 12000 ng/mL were found 
to be 77.33, 74.65, 79.94% and 70.59, 84.91, 75.57 %, 
respectively (Table I).
Precision and accuracy
Precision of the method was determined by 
repeatability (intraday) and intermediate precision (inter-
day) and accuracy for a set of quality control (QC) samples 
(low, mid, high) in replicate (n = 5).The inter-day and intra-
day precision and accuracy for the hydrochlorothiazide 
and metoprolol tartarate evaluated by assaying the QC 
samples (low, mid, high) (n = 5) were expressed in 
(%RSD). In this assay, the intra-run precision was found 
to be in the range of 0.53-3.17% and 1.29-4.24% whereas 
the inter-run precision was 1.2-1.51% and 1.43-1.7%. The 
accuracy was within 1.10–2.67%. The above values were 
within the acceptable range, showing that the methods are 
accurate and precise. The low percent relative standard 
deviation (%RSD) and percent relative error (%RE) were 
within acceptable limits. The results of inter-day, intra-day 
precision, and accuracy for the hydrochlorothiazide and 
metoprolol tartarate are shown in Table II.
Sensitivity and selectivity
Selectivity or specificity should be assessed to 
show that the intended analytes are measured and that 
their quantitation is not affected by the presence of the 
biological matrix. For the HPTLC method by protein 
precipitation, as shown in Figure 3, there was no 
interference by the biological matrix in the quantitation of 
hydrochlorothiazide and metoprolol tartarate. There were 
no changes in the retention factor of hydrochlorothiazide 
and metoprolol tartarate, where the method proved 
selective. Sensitivity of the method is defined as the 
lowest concentration that can be measured with an 
acceptable limit of accuracy and precision which is lower 
than 20% (Bansal, 2007). The accuracy and precision at 
the lower limit of quantitation (LLOQ) was analyzed by 
using five replicates (n = 5) of the sample at the LLOQ 
concentration. The accuracy was determined by %RE at 
this LLOQ concentration. The lower limits of quantitation 
detected were found to be 200 ng/mL and 2000 ng/mL 
with %RE = 17.8, 13.43 and %RSD= 10.74, 4.11 for 
hydrochlorothiazide and metoprolol tartarate, lying within 
the acceptable limit. 
Stability
In bench-top stability, the low and high QC sample 
were thawed and left at room temperature for 12 h. 
Comparison of the results for the QC sample (low and high) 
with freshly prepared stock solution showed that there was 
no significant difference between response of freshly 
prepared solution and sample of hydrochlorothiazide 
and metoprolol tartarate after 12 h. Freeze–thaw stability 
was determined after two freeze–thaw cycles for three 
replicates of low and high QC samples. The samples were 
stored at −20 ◦C temperature for 24 h. They were then 
thawed at room temperature. No significant difference 
between freeze–thaw samples and freshly prepared 
samples was observed. The result of stability experiments 
showed that no significant degradation occurred at ambient 
temperature for 48 h for post-preparative stability. Results 
of stability for the HPTLC method are shown in Table III.
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CONCLUSION
The proposed HPTLC method for the estimation of 
metoprolol tartarate and hydrochlorothiazide in human 
plasma by protein precipitation is both selective and 
sensitive. The sensitivity of the method is suitable for 
handling various plasma levels of the drug. The method is 
economical and faster than previously published methods.
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